Showing results 2 to 2 of 2
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
MPN-545 Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide as Second Line Therapy in Essential Thrombocythemia Proceeding/Conference:Clinical Lymphoma Myeloma and Leukemia | 2022 |